Does Rallies show Form 4 insider transactions for TNYA?

Yes. Rallies tracks TNYA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is TNYA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TNYA. It does not provide personalized investment advice.

TNYA (Tenaya Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Tenaya Therapeutics, Inc. Common Stock (TNYA) is a publicly traded Healthcare sector company. As of May 21, 2026, TNYA trades at $0.79 with a market cap of $169.91M and a P/E ratio of -1.74. TNYA moved +2.73% today. Year to date, TNYA is +10.94%; over the trailing twelve months it is +69.73%. Its 52-week range spans $0.36 to $4.01. Analyst consensus is strong buy with an average price target of $12.00. Rallies surfaces TNYA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading TNYA stock inside the company?

Recent TNYA insider activity includes Ali Faraz sold 3.39K, Tingley Whittemore sold 3.12K, Higa Tomohiro sold 1.49K, COLUMN GROUP III GP, LP sold 1.65M, and COLUMN GROUP III GP, LP sold 1.86M. Rallies tracks insider transaction dates, shares, prices, and estimated values.

TNYA Key Metrics

Key financial metrics for TNYA
Metric	Value
Price	$0.79
Market Cap	$169.91M
P/E Ratio	-1.74
EPS	$-0.46
Dividend Yield	0.00%
52-Week High	$4.01
52-Week Low	$0.36
Volume	53.22K
Avg Volume	0
Revenue (TTM)	$225.00K
Net Income	$-83.00M
Gross Margin	0.00%

Recent TNYA Insider Trades

Ali Faraz sold 3.39K (~$2.69K) on May 18, 2026.
Tingley Whittemore sold 3.12K (~$2.48K) on May 18, 2026.
Higa Tomohiro sold 1.49K (~$1.18K) on May 18, 2026.
COLUMN GROUP III GP, LP sold 1.65M (~$927.56K) on Feb 25, 2026.
COLUMN GROUP III GP, LP sold 1.86M (~$1.05M) on Feb 25, 2026.

Latest TNYA News

Tenaya to Reveal One-Year TN-401 ARVC Data and Q2 MyPEAK-1 Updates — May 6, 2026
Tenaya to Detail TN-401 Safety and Efficacy at 3E13 and 6E13 vg/kg Doses at ASGCT — Apr 27, 2026
Tenaya Extends Cash Runway to H2 2027 After $55.8M Financing and Alnylam Deal — Mar 11, 2026
Tenaya Signs $1.23 Billion Alnylam Collaboration to Identify 15 Cardiovascular Targets — Mar 6, 2026

TNYA Analyst Consensus

6 analysts cover TNYA: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $12.00.

Common questions about TNYA

Who is trading TNYA stock inside the company?: Recent TNYA insider activity includes Ali Faraz sold 3.39K, Tingley Whittemore sold 3.12K, Higa Tomohiro sold 1.49K, COLUMN GROUP III GP, LP sold 1.65M, and COLUMN GROUP III GP, LP sold 1.86M. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TNYA?: Yes. Rallies tracks TNYA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TNYA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TNYA. It does not provide personalized investment advice.